P1.13-30 Neutrophil-To-Lymphocyte Ratio as a Prognostic Factor and Its Relationship to NSCLC Patient Outcomes in the REVEL Trial

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.887

Related search